Skip to Main Content

Author Details

Zhengping Zhuang
National Cancer Institute, National Institutes of Health
1994
391
70
PMIDPaper TitleJournal TitlePublished Year
36789415"Tumor Treating Fields" delivered via electromagnetic induction have varied effects across glioma cell lines and electric field amplitudes.bioRxiv2023
37750087Carrimycin, a first in-class anti-cancer agent, targets selenoprotein H to induce nucleolar oxidative stress and inhibit ribosome biogenesis.Cancer Pathog Ther2023
37511490TP5: A Novel Therapeutic Approach Targeting Aberrant and Hyperactive CDK5/p25 for the Treatment of Colorectal Carcinoma.Int J Mol Sci2023
37936697Application of toll-like receptors (TLRs) and their agonists in cancer vaccines and immunotherapy.Front Immunol2023
37453673A novel HIF2A mutation causes dyslipidemia and promotes hepatic lipid accumulation.Pharmacol Res2023
37018064Proteostasis Modulation in Germline Missense von Hippel Lindau Disease.Clin Cancer Res2023
37450881Pacak-Zhuang syndrome: a model providing new insights into tumor syndromes.Endocr Relat Cancer2023
37342258Intratumoral immunotherapy of murine pheochromocytoma shows no age-dependent differences in its efficacy.Front Endocrinol (Lausanne)2023
37173979Epigenetic Regulation in Primary CNS Tumors: An Opportunity to Bridge Old and New WHO Classifications.Cancers (Basel)2023
37339049A protocol for visualization of murine in situ neurovascular interfaces.STAR Protoc2023
37434263rWTC-MBTA: autologous vaccine prevents metastases via antitumor immune responses.J Exp Clin Cancer Res2023
37001383Lipin2 ameliorates diabetic encephalopathy via suppressing JNK/ERK-mediated NLRP3 inflammasome overactivation.Int Immunopharmacol2023
37030115The combination of immunotherapy and a glutamine metabolism inhibitor represents an effective therapeutic strategy for advanced and metastatic murine pancreatic adenocarcinoma.Int Immunopharmacol2023
36353857A 13-Year-Old Male With Left Eye Swelling.Pediatrics2022
35489703Somatic Mosaicism of EPAS1 Mutations in Pacak-Zhuang Syndrome.Endocr Pract2022
35387667Targeting selenoprotein H in the nucleolus suppresses tumors and metastases by Isovalerylspiramycin I.J Exp Clin Cancer Res2022
35813464Isovalerylspiramycin I suppresses non-small cell lung carcinoma growth through ROS-mediated inhibition of PI3K/AKT signaling pathway.Int J Biol Sci2022
36572976Acute worsening of CADASIL in a patient with COVID-19 infection: illustrative case.J Neurosurg Case Lessons2022
36342229Targeting PP2A for cancer therapeutic modulation.Cancer Biol Med2022
33049075C-Terminal, but Not Intact, FGF23 and EPO Are Strongly Correlatively Elevated in Patients With Gain-of-Function Mutations in HIF2A: Clinical Evidence for EPO Regulating FGF23.J Bone Miner Res2021
33810617Mannan-BAM, TLR Ligands, Anti-CD40 Antibody (MBTA) Vaccine Immunotherapy: A Review of Current Evidence and Applications in Glioblastoma.Int J Mol Sci2021
33776908Succinate Mediates Tumorigenic Effects <i>via</i> Succinate Receptor 1: Potential for New Targeted Treatment Strategies in Succinate Dehydrogenase Deficient Paragangliomas.Front Endocrinol (Lausanne)2021
33497361Developmental vascular malformations in EPAS1 gain-of-function syndrome.JCI Insight2021
33855601Mannan-BAM, TLR ligands, and anti-CD40 immunotherapy in established murine pancreatic adenocarcinoma: understanding therapeutic potentials and limitations.Cancer Immunol Immunother2021
34945804Endogenous Retroviral Elements in Human Development and Central Nervous System Embryonal Tumors.J Pers Med2021
34439097Identification of Immune Cell Infiltration in Murine Pheochromocytoma during Combined Mannan-BAM, TLR Ligand, and Anti-CD40 Antibody-Based Immunotherapy.Cancers (Basel)2021
34638252Pharmacological Inhibition of PP2A Overcomes Nab-Paclitaxel Resistance by Downregulating MCL1 in Esophageal Squamous Cell Carcinoma (ESCC).Cancers (Basel)2021
34546977Tentorial venous anatomy of mice and humans.JCI Insight2021
34721537Down-Regulated CLDN10 Predicts Favorable Prognosis and Correlates With Immune Infiltration in Gastric Cancer.Front Genet2021
34145313SMARCB1 deletion in atypical teratoid rhabdoid tumors results in human endogenous retrovirus K (HML-2) expression.Sci Rep2021
34335453Multimodal Atlas of the Murine Inner Ear: From Embryo to Adult.Front Neurol2021
32342332Inhibition of protein phosphatase-2A with LB-100 enhances antitumor immunity against glioblastoma.J Neurooncol2020
33575476Metformin enhances anti-cancer effects of cisplatin in meningioma through AMPK-mTOR signaling pathways.Mol Ther Oncolytics2020
33709018Induction of Immune Response Against Metastatic Tumors via Vaccination of Mannan-BAM, TLR Ligands and Anti-CD40 Antibody (MBTA).Adv Ther (Weinh)2020
31876943Vascular Changes in the Retina and Choroid of Patients With EPAS1 Gain-of-Function Mutation Syndrome.JAMA Ophthalmol2020
31876082Clinical manifestations of Pacak-Zhuang syndrome in a male pediatric patient.Pediatr Blood Cancer2020
31935881Inhibition of PP2A with LB-100 Enhances Efficacy of CAR-T Cell Therapy Against Glioblastoma.Cancers (Basel)2020
32011210Targeting PP2A inhibits the growth of triple-negative breast cancer cells.Cell Cycle2020
33189686A Novel In Vitro Device to Deliver Induced Electromagnetic Fields to Cell and Tissue Cultures.Biophys J2020
33101674Metabolic plasticity of IDH1<i>-mutant</i> glioma cell lines is responsible for low sensitivity to glutaminase inhibition.Cancer Metab2020
32708903TP5, a Peptide Inhibitor of Aberrant and Hyperactive CDK5/p25: A Novel Therapeutic Approach against Glioblastoma.Cancers (Basel)2020
32337341Neuraxial dysraphism in <i>EPAS1-</i>associated syndrome due to improper mesenchymal transition.Neurol Genet2020
32274306Switching from Fatty Acid Oxidation to Glycolysis Improves the Outcome of Acute-On-Chronic Liver Failure.Adv Sci (Weinh)2020
32235007A novel germline gain-of-function HIF2A mutation in hepatocellular carcinoma with polycythemia.Aging (Albany NY)2020
32462735Metabolomics, machine learning and immunohistochemistry to predict succinate dehydrogenase mutational status in phaeochromocytomas and paragangliomas.J Pathol2020
32427851Somatic SF3B1 hotspot mutation in prolactinomas.Nat Commun2020
30530185CHCHD10 is involved in the development of Parkinson's disease caused by CHCHD2 loss-of-function mutation p.T61I.Neurobiol Aging2019
31648104Blocking lncRNA MALAT1/miR-199a/ZHX1 Axis Inhibits Glioblastoma Proliferation and Progression.Mol Ther Nucleic Acids2019
31739997Coley's immunotherapy revived: Innate immunity as a link in priming cancer cells for an attack by adaptive immunity.Semin Oncol2019
31185588Chiari Malformation Type 1 in <i>EPAS1</i>-Associated Syndrome.Int J Mol Sci2019
  • 1 - 50 of 391

Recommended Authors

Emory School of Medicine
Career Start Year 2008
Number of shared co-authors 2
Curie Institute Hospital Group
Career Start Year 2008
Number of shared co-authors 3
Mayo Clinic Foundation
Career Start Year 2007
Number of shared co-authors 1
University of California san francisco
Career Start Year 2003
Number of shared co-authors 9
Institut fur Pathologie, Universitatsmedizin Mannheim
Career Start Year 2000
Number of shared co-authors 2
From Foundation Medicine
Career Start Year 1999
Number of shared co-authors 17
Amsterdam University Medical Centers location AMC
Career Start Year 1999
Number of shared co-authors 5
Texas Children's Hospital
Career Start Year 1996
Number of shared co-authors 4
Memorial Sloan Kettering Cancer Center
Career Start Year 1996
Number of shared co-authors 2
University of Michigan Medical School ann arbor
Career Start Year 1995
Number of shared co-authors 1
Wilmer Eye Institute, Johns Hopkins Medical Institutions
Career Start Year 1993
Number of shared co-authors 12
Institute of Neuropathology, Heinrich Heine University
Career Start Year 1993
Number of shared co-authors 4
Nova Scotia Health Authority
Career Start Year 1992
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 3
Yale School of Medicine
Career Start Year 1989
Number of shared co-authors 4
Erasmus MC Cancer Institute, University Medical Center Rotterdam
Career Start Year 1988
Number of shared co-authors 6
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 1
Washington University School of Medicine
Career Start Year 1987
Number of shared co-authors 1
Heinrich Heine University
Career Start Year 1987
Number of shared co-authors 7
PSL Research University, Institut Curie Research Center, INSERM U, Institut Curie
Career Start Year 1987
Number of shared co-authors 6
German Cancer Research Center (DKFZ)
Career Start Year 1986
Number of shared co-authors 12
Oregon Health & Science University
Career Start Year 1985
Number of shared co-authors 4
Memorial Sloan Kettering Cancer Center
Career Start Year 1984
Number of shared co-authors 10
The University of Texas M. D. Anderson Cancer Center
Career Start Year 1984
Number of shared co-authors 0
University of Sao Paulo
Career Start Year 1982
Number of shared co-authors 3
Baylor College of Medicine
Career Start Year 1982
Number of shared co-authors 7
Ludwig Institute for Cancer Research, University of California San Diego
Career Start Year 1977
Number of shared co-authors 3
Foundation Medicine
Career Start Year 1974
Number of shared co-authors 4
Center for Epigenetics, Van Andel Research Institute
Career Start Year 1971
Number of shared co-authors 7
Mount Sinai Hospital
Career Start Year 1943
Number of shared co-authors 8

Collaborators

Indiana University School of Medicine
Co-authored papers 122
National Cancer Institute, National Institutes of Health
Co-authored papers 67
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Co-authored papers 62
National Institutes of Health
Co-authored papers 50
The Francis Crick Institute
Co-authored papers 45
Co-authored papers 41
Rhode Island Hospital
Co-authored papers 40
Co-authored papers 31
National Cancer Institute, National Institutes of Health
Co-authored papers 25
Yale University School of Medicine
Co-authored papers 24
National Institutes of Digestive Disease and Kidney, National Institutes of Health
Co-authored papers 23
Albert Einstein College of Medicine
Co-authored papers 19
National Institutes of Health
Co-authored papers 18
University of Michigan ann arbor
Co-authored papers 17
National Eye Institute, National Institutes of Health
Co-authored papers 17
Vrije Universiteit Brussel
Co-authored papers 16
Saga-Ken Medical Centre Koseikan Department of Neurosurgery, Saga University
Co-authored papers 15
National Institute of Diabetes and Digestive and Kidney Diseases
Co-authored papers 15
National Eye Institute, National Institutes of Health
Co-authored papers 13
McLean Hospital
Co-authored papers 11
National Institute of Neurological Disorders and Stroke
Co-authored papers 7
National Human Genome Research Institute
Co-authored papers 5
Center for Cancer Research, National Cancer Institute
Co-authored papers 5
National Cancer Institute, National Institutes of Health
Co-authored papers 5
Co-authored papers 5
National Cancer Institute, National Institutes of Health
Co-authored papers 5
Institute of Molecular and Cell Biology
Co-authored papers 4
National Cancer Institute (NCI), National Institutes of Health (NIH)
Co-authored papers 4
Stanford University School of Medicine
Co-authored papers 4
National Eye Institute
Co-authored papers 4